Dow Jones Today, Stocks Climb Into Short Session After AstraZeneca Vaccine Bump - Investor's Business Daily

Intel and Amgen took early leads on the Dow Jones today.

The Nasdaq led in early trade, opening 0.7% higher as chipmakers crowded in just behind Tesla at the top of the index.

The S&P 500 added 0.3% on stock market today, while the Dow industrials swung 0.5% higher, pushing back above the 30,000 mark.

Moderna shares were up more than 27% after a breakout from what IBD MarketSmith chart analysis plots as a 95.31 buy point in a 17-week cup base on Nov.

BioNTech shares gained 4.7% in early action.

Salesforce.com (CRM) moved up 0.9% to trade high on the Dow Jones today.

Slack shares were down 4.7% early Friday.

The stock ended Wednesday about 10% above a 41.09 buy point after a Nov.

Shares were about 7% below a potential buy point at 154.98, as the stock moves to finish off the sixth week of a possible cup base.

Join IBD experts as they analyze actionable stocks in the stock market rally on IBD Live.

November wild-ride stock Palantir Technologies (PLTR) popped 7.1% early Friday.

A four-week advance following the breakout from an IPO base left shares, at the end of trade on Wednesday, up more than 188% since the start of the month.

The Dow Jones today jumps into the short post-Thanksgiving session with a November gain of 12.7%.

For more detailed analysis of the current stock market and its status, study the Big Picture.

The SPDR Dow Jones Industrial Average ETF Trust (DIA), tracking the Dow industrials, traded up 0.2% early Friday.

Shares were in a buy range, 3% over the entry, at the end of trade on Wednesday.

 The Vanguard Russell 2000 Index Fund ETF Shares (VTWO) also broke out on Nov.

Shares were extended, up 8% above that buy point on Wednesday.

IBD Digital: Unlock IBD's Premium Stock Lists, Tools And Analysis Today.

Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5

Get market updates, educational videos, webinars, and stock analysis

Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content